These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34772541)

  • 1. Anti-AT1R autoantibodies and prediction of the severity of Covid-19.
    Papola F; Biancofiore V; Angeletti C; Grimaldi A; Carucci AC; Cofini V; Necozione S; Rosciano A; Marinangeli F; Cervelli C
    Hum Immunol; 2022 Feb; 83(2):130-133. PubMed ID: 34772541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset IgG autoantibodies in hospitalized patients with COVID-19.
    Chang SE; Feng A; Meng W; Apostolidis SA; Mack E; Artandi M; Barman L; Bennett K; Chakraborty S; Chang I; Cheung P; Chinthrajah S; Dhingra S; Do E; Finck A; Gaano A; Geßner R; Giannini HM; Gonzalez J; Greib S; Gündisch M; Hsu AR; Kuo A; Manohar M; Mao R; Neeli I; Neubauer A; Oniyide O; Powell AE; Puri R; Renz H; Schapiro J; Weidenbacher PA; Wittman R; Ahuja N; Chung HR; Jagannathan P; James JA; Kim PS; Meyer NJ; Nadeau KC; Radic M; Robinson WH; Singh U; Wang TT; Wherry EJ; Skevaki C; Luning Prak ET; Utz PJ
    Nat Commun; 2021 Sep; 12(1):5417. PubMed ID: 34521836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
    Cabral-Marques O; Halpert G; Schimke LF; Ostrinski Y; Vojdani A; Baiocchi GC; Freire PP; Filgueiras IS; Zyskind I; Lattin MT; Tran F; Schreiber S; Marques AHC; Plaça DR; Fonseca DLM; Humrich JY; Müller A; Giil LM; Graßhoff H; Schumann A; Hackel A; Junker J; Meyer C; Ochs HD; Lavi YB; Scheibenbogen C; Dechend R; Jurisica I; Schulze-Forster K; Silverberg JI; Amital H; Zimmerman J; Heidecke H; Rosenberg AZ; Riemekasten G; Shoenfeld Y
    Nat Commun; 2022 Mar; 13(1):1220. PubMed ID: 35264564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-Angiotensin System Dysregulation: ADAM17 Activation Consequences Related to SARS-CoV-2.
    Giacomoni J; Sabatier JM
    Infect Disord Drug Targets; 2024 Apr; ():. PubMed ID: 38685806
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
    Jiang Y; Duffy F; Hadlock J; Raappana A; Styrchak S; Beck I; Mast FD; Miller LR; Chour W; Houck J; Armistead B; Duvvuri VR; Yeung W; Haglund M; Wallner J; Wallick JA; Hardy S; Oldroyd A; Ko D; Gervassi A; Murray KM; Kaplan H; Aitchison JD; Heath JR; Sather DN; Goldman JD; Frenkel L; Harrington WE
    PLoS One; 2021; 16(11):e0259902. PubMed ID: 34788328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
    CORIMUNO-19 Collaborative group
    Lancet Rheumatol; 2022 Jan; 4(1):e24-e32. PubMed ID: 34812424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
    Boussier J; Yatim N; Marchal A; Hadjadj J; Charbit B; El Sissy C; Carlier N; Pène F; Mouthon L; Tharaux PL; Bergeron A; Smadja DM; Rieux-Laucat F; Duffy D; Kernéis S; Frémeaux-Bacchi V; Terrier B
    J Allergy Clin Immunol; 2022 Feb; 149(2):550-556.e2. PubMed ID: 34800432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity.
    Abela IA; Pasin C; Schwarzmüller M; Epp S; Sickmann ME; Schanz MM; Rusert P; Weber J; Schmutz S; Audigé A; Maliqi L; Hunziker A; Hesselman MC; Niklaus CR; Gottschalk J; Schindler E; Wepf A; Karrer U; Wolfensberger A; Rampini SK; Meyer Sauteur PM; Berger C; Huber M; Böni J; Braun DL; Marconato M; Manz MG; Frey BM; Günthard HF; Kouyos RD; Trkola A
    Nat Commun; 2021 Nov; 12(1):6703. PubMed ID: 34795285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Risk Factors and Mortality Outcomes Among Medicare Patients Receiving Long-term Dialysis.
    Salerno S; Messana JM; Gremel GW; Dahlerus C; Hirth RA; Han P; Segal JH; Xu T; Shaffer D; Jiao A; Simon J; Tong L; Wisniewski K; Nahra T; Padilla R; Sleeman K; Shearon T; Callard S; Yaldo A; Borowicz L; Agbenyikey W; Horton GM; Roach J; Li Y
    JAMA Netw Open; 2021 Nov; 4(11):e2135379. PubMed ID: 34787655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
    Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
    Front Immunol; 2021; 12():738093. PubMed ID: 34777349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.
    Mazeraud A; Jamme M; Mancusi RL; Latroche C; Megarbane B; Siami S; Zarka J; Moneger G; Santoli F; Argaud L; Chillet P; Muller G; Bruel C; Asfar P; Beloncle F; Reignier J; Vinsonneau C; Schimpf C; Amour J; Goulenok C; Lemaitre C; Rohaut B; Mateu P; De Rudnicki S; Mourvillier B; Declercq PL; Schwebel C; Stoclin A; Garnier M; Madeux B; Gaudry S; Bailly K; Lamer C; Aegerter P; Rieu C; Sylla K; Lucas B; Sharshar T
    Lancet Respir Med; 2022 Feb; 10(2):158-166. PubMed ID: 34774185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and predictive value of biomarkers with severe outcomes in hospitalized patients with SARS-CoV-2 infection.
    Fernandez-Botran R; Furmanek S; Ambadapoodi RS; Expósito González E; Cahill M; Carrico R; Akca O; Ramírez JA;
    Cytokine; 2022 Jan; 149():155755. PubMed ID: 34773859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM17/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID-19.
    Lartey NL; Valle-Reyes S; Vargas-Robles H; Jiménez-Camacho KE; Guerrero-Fonseca IM; Castellanos-Martínez R; Montoya-García A; García-Cordero J; Cedillo-Barrón L; Nava P; Filisola-Villaseñor JG; Roa-Velázquez D; Zavala-Vargas DI; Morales-Ríos E; Salinas-Lara C; Vadillo E; Schnoor M
    J Leukoc Biol; 2022 Jun; 111(6):1147-1158. PubMed ID: 34826347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia.
    Basheer M; Saad E; Shlezinger D; Assy N
    Metabolites; 2021 Nov; 11(11):. PubMed ID: 34822419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study.
    Janssen MT; Ramiro S; Mostard RL; Magro-Checa C; Landewé RB
    RMD Open; 2021 Nov; 7(3):. PubMed ID: 34819387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
    Liu Y; Liu J; Plante KS; Plante JA; Xie X; Zhang X; Ku Z; An Z; Scharton D; Schindewolf C; Widen SG; Menachery VD; Shi PY; Weaver SC
    Nature; 2022 Feb; 602(7896):294-299. PubMed ID: 34818667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection.
    Fodor E; Müller V; Iványi Z; Berki T; Kuten Pella O; Hornyák I; Ambrus M; Sárkány Á; Skázel Á; Madár Á; Kardos D; Kemenesi G; Földes F; Nagy S; Matusovits A; János N; Tordai A; Jakab F; Lacza Z
    Infect Dis Ther; 2022 Feb; 11(1):293-304. PubMed ID: 34817840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive Anticoagulation May Decrease Mortality in Obese Critically Ill COVID-19 Patients.
    Drakos P; Volteas P; Naeem Z; Asencio AA; Cleri NA; Alkadaa LN; Oganov A; Gammel T; Saadon JR; Bannazadeh M; Tassiopoulos AK; Mikell CB; Rubano J; Pryor A; Spaniolas K; Mofakham S
    Obes Surg; 2022 Feb; 32(2):391-397. PubMed ID: 34816357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.
    Heitmann JS; Bilich T; Tandler C; Nelde A; Maringer Y; Marconato M; Reusch J; Jäger S; Denk M; Richter M; Anton L; Weber LM; Roerden M; Bauer J; Rieth J; Wacker M; Hörber S; Peter A; Meisner C; Fischer I; Löffler MW; Karbach J; Jäger E; Klein R; Rammensee HG; Salih HR; Walz JS
    Nature; 2022 Jan; 601(7894):617-622. PubMed ID: 34814158
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.